Recruiting NA INTERVENTIONAL 2-arm NCT06365502

Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

A Multicenter, Prospective, Open-label, Controlled, Randomized Trial of Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

Sponsor: Harbin Medical University

Conditions Acute Coronary Syndrome (ACS)

Interventions Drug-coated balloon Guideline-directed medical treatment

Updated 4 times since 2024 Last updated: May 21, 2024 Started: Apr 16, 2024 Primary completion: Dec 31, 2027 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Coronary Syndrome (ACS) and is currently actively recruiting participants. Harbin Medical University leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
May 2024 — Jun 2024 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Harbin Medical University
Shanghai Shenqi Medical Technology Co., Ltd

Data source: Harbin Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijin, China , Changchun, China , Dalian, China , Daqing, China , Harbin, China , Hohhot, China , Jiamusi, China , Jinan, China , Jining, China , Mudanjiang, China and 6 more locations